Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00965991 · ClinicalTrials.gov registry record · NA
Metformin Compared to Glyburide in Gestational Diabetes
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 149
- Enrollment target
NCT00965991 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 149 participants.
The verdict
NCT00965991, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
Study Summary
Our hypothesis is that metformin and glyburide will have equal efficacy in controlling blood glucose in gestational diabetics with no increase in adverse maternal, fetal or neonatal outcomes.
Interventions
- DRUG metformin
- DRUG Glyburide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2003-07 |
| Est. Completion | 2023-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00965991
The ClinicalTrials.gov registry entry for NCT00965991 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which metformin is the first listed.
NCT00965991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00965991 about?
NCT00965991 is a clinical study titled "Metformin Compared to Glyburide in Gestational Diabetes". Our hypothesis is that metformin and glyburide will have equal efficacy in controlling blood glucose in gestational diabetics with no increase in adverse maternal, fetal or neonatal outcomes.
What is the current status of trial NCT00965991?
This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2003-07. Estimated completion is 2023-08.
What interventions are being tested in trial NCT00965991?
The interventions under investigation include: metformin (DRUG), Glyburide (DRUG).
Who is sponsoring clinical trial NCT00965991?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.